A field evaluation of the Hardy TB MODS kit™ for the rapid phenotypic diagnosis of tuberculosis and multi-drug resistant tuberculosis

PLoS ONE

Volumn 9, Issue 9, 2014, Pages

  Martin, Laura ^a,b   Coronel, Jorge ^a   Faulx, Dunia ^c   Valdez, Melissa ^c   Metzler, Mutsumi ^c   Crudder, Chris ^c   Castillo, Edith ^d   Caviedes, Luz ^a   Grandjean, Louis ^a,b   Rodriguez, Mitzi ^d   Friedland, Jon S ^b   Gilman, Robert H ^a,e   Moore, David A J ^a,e,f  

^a UNIVERSIDAD PERUANA CAYETANO HEREDIA   (Peru)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

^c PATH   (United States)

^d Gerencia Regional de Salud del Callao   (Peru)

^e JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^f LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ISONIAZID; RIFAMPICIN; SILICONE; DIAGNOSTIC KIT; TUBERCULOSTATIC AGENT;

ARTICLE; BACTERIUM DETECTION; BIOASSAY; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; CULTURE MEDIUM; DIAGNOSTIC KIT; DRUG SENSITIVITY; HUMAN; INTERMETHOD COMPARISON; LOWENSTEIN JENSEN ASSAY; MICROSCOPIC OBSERVATION DRUG SUSCEPTIBILITY ASSAY; MULTIDRUG RESISTANT TUBERCULOSIS; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PHENOTYPE; PREDICTIVE VALUE; SENSITIVITY AND SPECIFICITY; SPUTUM CULTURE; STANDARD; TUBERCULOSIS; DRUG EFFECTS; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; PERU; PROCEDURES; REPRODUCIBILITY; SPUTUM; TUBERCULOSIS, MULTIDRUG-RESISTANT;

ANTITUBERCULAR AGENTS; HUMANS; ISONIAZID; MICROBIAL SENSITIVITY TESTS; MYCOBACTERIUM TUBERCULOSIS; PERU; REAGENT KITS, DIAGNOSTIC; REPRODUCIBILITY OF RESULTS; RIFAMPIN; SENSITIVITY AND SPECIFICITY; SPUTUM; TUBERCULOSIS; TUBERCULOSIS, MULTIDRUG-RESISTANT;

EID: 84907185193     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0107258     Document Type: Article

References (23)

1. WHO | Global tuberculosis report 2013 (n.d.). WHO. Available: http://www.who.int/tb/publications/global-report/en/. Accessed 2014 April 13.
2. Caviedes L, Lee TS, Gilman RH, Sheen P, Spellman E, et al. (2000) Rapid, efficient detection and drug susceptibility testing of Mycobacterium tuberculosis in sputum by microscopic observation of broth cultures. The Tuberculosis Working Group in Peru. J Clin Microbiol 38: 1203-1208.
3. Moore DAJ, Mendoza D, Gilman RH, Evans CAW, Hollm Delgado M-G, et al. (2004) Microscopic observation drug susceptibility assay, a rapid, reliable diagnostic test for multidrug-resistant tuberculosis suitable for use in resource-poor settings. J Clin Microbiol 42: 4432-4437. doi:10.1128/JCM.42.10.4432-4437.2004.
4. Moore DAJ, Evans CAW, Gilman RH, Caviedes L, Coronel J, et al. (2006) Microscopic-observation drug-susceptibility assay for the diagnosis of TB. N Engl J Med 355: 1539-1550. doi:10.1056/NEJMoa055524.
5. Noncommercial Culture and Drug-Susceptibility Testing Methods for Screening Patients at Risk for Multidrug-Resistant Tuberculosis: Policy Statement (2011). Geneva: World Health Organization. Available: http://www.ncbi.nlm.nih.gov/books/NBK131916/. Accessed 2013 Dec 8.
6. Universidad Peruana Cayetano Heredia (n.d.) MODS Peru. Available: http://www.modsperu.org/. Accessed 2013 Sept 26.
7. Mauch V, Weil D, Munim A, Boillot F, Coninx R, et al. (2010) Structure and management of tuberculosis control programs in fragile states-Afghanistan, DR Congo, Haiti, Somalia. Health Policy 96: 118-127. doi:10.1016/j.healthpol.2010.01.003.
8. Microbiology Culture Media and Laboratory Supplies - by Hardy Diagnostics (n.d.). Available: http://hardydiagnostics.com/. Accessed 2013 Sept 28.
9. PATH: A catalyst for global health (n.d.). Available: http://www.path.org/. Accessed 2013 Sept 28.
10. WHO | Tuberculosis laboratory biosafety manual. (n.d.). WHO. Available: http://www.who.int/tb/publications/2012/tb-biosafety/en/index.html. Accessed 2013 Dec 8.
11. Public Health Mycobacteriology: A guide for the level III laboratory.Kent, P.T. and G.P. Kubica Vol. CDC 86-216547. 1985 (1985). Atlanta: Center for Disease Control.
12. Laboratory services in TB control. Parts I, II, and III. Geneva: World Health Organization, 1998. Publication no.WHO/tb/98.258. 1998.
13. Miotto P, Piana F, Penati V, Canducci F, Migliori GB, et al. (2006) Use of genotype MTBDR assay for molecular detection of rifampin and isoniazid resistance in Mycobacterium tuberculosis clinical strains isolated in Italy. J Clin Microbiol 44: 2485-2491. doi:10.1128/JCM.00083-06.
14. Minion J, Leung E, Menzies D, Pai M (2010) Microscopic-observation drug susceptibility and thin layer agar assays for the detection of drug resistant tuberculosis: a systematic review and meta-analysis. Lancet Infect Dis 10: 688-698. doi:10.1016/S1473-3099(10)70165-1.
15. Coronel J, Roper MH, Herrera C, Bonilla C, Jave O, et al. (2013) Validation of MODS for rapid, direct rifampicin and isoniazid drug susceptibility testing in patients receiving TB treatment. Clin Microbiol Infect Off Publ Eur Soc Clin Microbiol Infect Dis. doi:10.1111/1469-0691.12401.
16. Moore DAJ, Caviedes L, Gilman RH, Coronel J, Arenas F, et al. (2006) Infrequent MODS TB culture cross-contamination in a high-burden resource-poor setting. Diagn Microbiol Infect Dis 56: 35-43. doi:10.1016/j.diagmicrobio.2006.03.009.
17. Shah NS, Moodley P, Babaria P, Moodley S, Ramtahal M, et al. (2011) Rapid diagnosis of tuberculosis and multidrug resistance by the microscopic-observation drug-susceptibility assay. Am J Respir Crit Care Med 183: 1427-1433. doi:10.1164/rccm.201009-1449OC.
18. Limaye K, Kanade S, Nataraj G, Mehta P (2010) Utility of Microscopic Observation of Drug Susceptibility (MODS) assay for Mycobacterium tuberculosis in resource constrained settings. Indian J Tuberc 57: 207-212.
19. Shiferaw G, Woldeamanuel Y, Gebeyehu M, Girmachew F, Demessie D, et al. (2007) Evaluation of microscopic observation drug susceptibility assay for detection of multidrug-resistant Mycobacterium tuberculosis. J Clin Microbiol 45: 1093-1097. doi:10.1128/JCM.01949-06.
20. Grandjean L, Martin L, Gilman RH, Valencia T, Herrera B, et al. (2008) Tuberculosis diagnosis and multidrug resistance testing by direct sputum culture in selective broth without decontamination or centrifugation. J Clin Microbiol 46: 2339-2344. doi:10.1128/JCM.02476-07.
21. Solari L, Gutiérrez A, Suárez C, Jave O, Castillo E, et al. (2011) Cost Analysis of Rapid Methods for Diagnosis of Multidrug Resistant Tuberculosis in Different Epidemiologic groups in Peru. Rev Peru Med Exp Salud Publica 28: 426-431.
22. Fitzwater SP, Sechler GA, Jave O, Coronel J, Mendoza A, et al. (2012) Second-line anti-TB drug concentrations for susceptibility testing in the MODS assay. Eur Respir J. Available: http://erj.ersjournals.com/content/early/2012/08/ 16/09031936.00059812. Accessed 2013 April 22.
23. Trollip AP, Moore D, Coronel J, Caviedes L, Klages S, et al. (2014) Second-line drug susceptibility breakpoints for Mycobacterium tuberculosis using the MODS assay. Int J Tuberc Lung Dis Off J Int Union Tuberc Lung Dis 18: 227-232. doi:10.5588/ijtld.13.0229.